Brief: Roquefort Therapeutics Says STAT-6 SIRNA Shows Efficacy In Immunology Model
Sept 19 (Reuters) - Roquefort Therapeutics PLC ROQ.L :
* STAT-6 SIRNA DEMONSTRATES EFFICACY IN IMMUNOLOGY
* STAT-6 SIRNA SHOWS EFFICACY IN IMMUNOLOGY MODEL
Source text for Eikon: ID:nRSS7436Ea
Further company coverage: ROQ.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Coiled Therapeutics
See all newsRCS - Coiled Therapeutics - Investor Presentation via Engage Investor
RCS - Coiled Therapeutics - Participation in The Small Cap Showcase
Coiled Therapeutics - Director/PDMR Shareholding
Coiled Therapeutics - Interim Results to 30 June 2026
Coiled Therapeutics - Successful Enrolment Completed Across Two Cohorts